β-Amyloid Peptide and the Alzheimer’s Disease
Title Talk: β-Amyloid Peptide and the Alzheimer’s Disease
Author: Dr. Tshetiz Dahal (MBBS)
General Physician/Clinical Researcher and Writer
Lugansk State Medical University, Luhansk Oblast, 93000 Luhansk, Ukraine
Email: dahaltshetiz21@gmail.com
ORCID ID : https://orcid.org/0000-0002-4042-7768
Twitter : @DrTshetiz
Volume: Memory Disorders 2023_CN36_AA02
International Live Conference on Memory Disorders and Conditions
Date: June 03, 2023
Time: 8 PM Indian Standard Time
Location: Online
Conference Theme: Unraveling the Mysteries of Memory Disorders
Abstract:
The formation and deposition of the -amyloid peptide (A) are largely thought to be responsible for the development of Alzheimer's disease (AD). Researchers have been perplexed by the sluggish to nonexistent association between the degree of clinical dementia and the amount of neuritic plaque disease in the human brain for a long time. This question has been resolved thanks to recent developments in our knowledge of the origins of amyloid disease. The solubility of A and the amount of A in various pools may now be more directly tied to disease state, according to substantial evidence. The make-up of these pools of A reflects various populations of amyloid deposits and is clearly correlated with the patient's clinical condition. Using imaging methods, such as novel amyloid imaging agents based on the chemical makeup of histology dyes, it is now possible to monitor the development of the disease in a living patient while also monitoring the amyloid pathology. It's interesting that these methods show that the A deposited in AD differs from that discovered in animal models. In general, deposited A does not exhibit the same physical and biochemical properties as the amyloid observed in AD and is more readily removed from the brain in animal studies. Important questions about the creation and evaluation of potential medicinal agents are brought up by this. Biography: Dr. Tshetiz Dahal is a General Physician, Clinical Researcher, and Writer. He is affiliated with Lugansk State Medical University in Ukraine and China Three Gorges University in China. Dr. Dahal has excellent communication and writing skills in English, Nepali, Hindi, Sanskrit, Simplified Chinese, Russian, and Bengali.
As a General Physician, Dr. Dahal is highly organized, empathetic, and dedicated to providing excellent patient care. He is skilled in taking medical histories, performing physical and surgical examinations, and diagnosing acute and chronic conditions. In addition to his clinical practice, Dr. Dahal is also involved in medical research and writing.
Dr. Dahal has published several research papers in reputable journals, including the Journal of Neurology and Neuroscience, ClinMed International Library - Science Resource Online, Journal of Cancer Diagnosis, Journal of Neurosurgery and Neurology Research, Research & Reviews: A Journal of Neuroscience, International Journal of Advanced Research (IJAR), Cancer Treatment, Biomarkers and Prevention, Biomedical - Journal of Scientific and Technical Research, HSOA Journal of Cancer Biology and Treatment, International Journal of Research in Engineering and Science (IJRES), IOSR Journal of Dental and Medical Sciences, International Journal Dental and Medical Sciences Research, Quest Journals - Journal of Medical and Dental Science Research, and International Journal of Recent Scientific Research.
In his research work, Dr. Dahal has focused on topics such as cerebral abscess, immuno-therapy in lung cancer, immune tolerance after liver transplantation, pancreatic cancer, cerebral palsy, neurological disorders in COVID-19, traumatic brain injury, cannabidiol's function in neurological disorders, and Alzheimer's disease neuropathological diagnosis.
Dr. Tshetiz Dahal is known for his expertise in clinical practice, research, and medical writing. He is a dedicated professional with a passion for improving healthcare and making a positive impact in the field of medicine.
